Sustainable financing

Many countries around the region are still heavily dependent on external funding for their national HIV and TB responses. Funding for HIV responses in Eastern Europe and Central Asia (excluding the Russian Federation) peaked in 2017, before declining by 14 percent between 2017 and 2019, leaving the region at just 56 percent of its 2020 resource target. HIV response funding from domestic sources increased by 24 percent from 2010 to 2019, with contributions from the Global Fund to Fight AIDS, Tuberculosis and Malaria and all other international sources decreased by 10 percent. There is a strong push by the Global Fund and other donors for countries to further increase domestic funding for their National HIV responses.

Ivan Zelenskiy, activist and leukemia patient, fights for better access he and other Ukrainian citizens need. UNDP has helped procure drugs more efficiently and transparently for the government, allowing more medicines to be available. Photo: Stanislav Vlasov / UNDP Ukraine

Given these developments, sustainable financing of national HIV and TB responses is a priority concern for many countries in this region. UNDP and its partners provide support to countries in the following areas:

Accessing affordable and quality HIV and TB medicines;
Investing their limited resources in the most impactful HIV and TB activities and programmes;
Helping governments transition national HIV and TB responses to more cost-efficient investment approaches; and
Supporting countries to recognize NGOs as critical partners in the delivery of HIV and TB services by establishing NGO social contracting as a critical part of sustainable financing of national responses.